Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
81 participants
INTERVENTIONAL
2018-08-27
2020-07-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mantra Meditation in Major Depression
NCT03004430
Meditation for Depression
NCT01671436
Implementation of a Multiple Intervention to Promote Healthy Lifestyles in Patients With Depression
NCT06990035
Lifestyle Medicine for Depression
NCT03720145
Effect of Short-Term Mindfulness-Based Training For Major Depression Disorder: An Eye-Tracking Study
NCT04071886
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control 2
Definitions 24 weeks Multimodal specific treatment
Minimal treatment: drug continuation under medical supervision Multimodal specific treatment: Drugs / Psychotherapy / Excercise therapy / Ergotherapy / Relaxation; excl. Yoga, Mantra, MBSR MBLM: 8-week course Meditation Based Lifestyle Modification MBLM-Consolidation: weekly Mantra-Meditation, monthly Life-Ethics
Multimodal specific treatment:
Drugs / Psychotherapy / Excercise therapy / Ergotherapy / Relaxation; excl. Yoga, Mantra, MBSR
Intervention
8 weeks Minimal treatment + MBLM 16 weeks Multimodal specific treatment + MBLM Consolidation
Definitions Minimal treatment: drug continuation under medical supervision Multimodal specific treatment: Drugs / Psychotherapy / Excercise therapy / Ergotherapy / Relaxation; excl. Yoga, Mantra, MBSR MBLM: 8-week course Meditation Based Lifestyle Modification MBLM-Consolidation: weekly Mantra-Meditation, monthly Life-Ethics
Meditation Based Lifestyle Modification
8 weekly modules, each 3.5 hours of Life ethics, Yoga exercises and Mantra Meditation
Control I
8 weeks Minimal treatment 16 weeks Multimodal specific treatment
Definitions Minimal treatment: drug continuation under medical supervision Multimodal specific treatment: Drugs / Psychotherapy / Excercise therapy / Ergotherapy / Relaxation; excl. Yoga, Mantra, MBSR MBLM: 8-week course Meditation Based Lifestyle Modification MBLM-Consolidation: weekly Mantra-Meditation, monthly Life-Ethics
Minimal treatment
Drug continuation under medical supervision
Multimodal specific treatment:
Drugs / Psychotherapy / Excercise therapy / Ergotherapy / Relaxation; excl. Yoga, Mantra, MBSR
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Meditation Based Lifestyle Modification
8 weekly modules, each 3.5 hours of Life ethics, Yoga exercises and Mantra Meditation
Minimal treatment
Drug continuation under medical supervision
Multimodal specific treatment:
Drugs / Psychotherapy / Excercise therapy / Ergotherapy / Relaxation; excl. Yoga, Mantra, MBSR
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Outpatients
2. Written informed consent by patients who are competent to consent to study participation
3. Diagnosis of current mild or moderate episode of depression diagnosed by a consultant psychiatrist
4. Male or female ≥18 years of age
5. BDI-II \>= 10
6. Patients must be physically able to perform simple Yoga postures and to sit silently for 20 minutes
Exclusion Criteria
1. Psychotic Symptoms
2. Acute suicidal tendencies
3. Compulsive disorders
4. Cerebro-organic diseases with clinically relevant symptoms
5. Severe multimorbidity
6. Clinically relevant addictions (tobacco abuse or addiction is allowed)
7. Current participation in another trial
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Chemnitz University of Technology
OTHER
Diakonie Kliniken Zschadraß
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Holger C. Bringmann
Dr. med. B. Sc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Diakoniekliniken Zschadraß
Colditz, Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bringmann HC, Berghofer A, Jeitler M, Michalsen A, Brunnhuber S, Haller H. Meditation-Based Lifestyle Modification in Mild-to-Moderate Depression: Outcomes and Moderation Effects of Spirituality. J Integr Complement Med. 2024 Jun;30(6):532-542. doi: 10.1089/jicm.2023.0179. Epub 2023 Nov 27.
Bringmann HC, Vennemann J, Gross J, Matko K, Sedlmeier P. "To Be Finally at Peace with Myself": A Qualitative Study Reflecting Experiences of the Meditation-Based Lifestyle Modification Program in Mild-to-Moderate Depression. J Altern Complement Med. 2021 Sep;27(9):786-795. doi: 10.1089/acm.2021.0038. Epub 2021 Jun 29.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MBLM-D
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.